Interestingly, the lack of CT-1 in animals improved insulin resistance, obesity, and dyslipidemia; by contrast, long-term administration of CT-1 diminished bodyweight and ameliorate insulin resistance in obese mice [15, 17]. Here, CTF1 is linked to metabolic syndrome.